Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

Yin Li; Ke Pan; Li-zhi Liu; Yong-qiang Li; Mo-fa Gu; Hua Zhang; Wei-xi Shen; Jian-chuan Xia; Jian-jun Li

doi:10.1371/journal.pone.0130620

Loading metrics

Open Access

Peer-reviewed

Research Article

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

Yin Li ,

Contributed equally to this work with: Yin Li, Ke Pan, Li-zhi Liu

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Ke Pan ,

Contributed equally to this work with: Yin Li, Ke Pan, Li-zhi Liu

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Li-zhi Liu ,

Contributed equally to this work with: Yin Li, Ke Pan, Li-zhi Liu

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Imaging and Invention Radiology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Yong-qiang Li,

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Mo-fa Gu,

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Radiation, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Hua Zhang,

Affiliation Cancer Center, The People’s Hospital of Guangdong Province, Guangzhou, 510089, P. R. China
⨯
Wei-xi Shen,

Affiliation Cancer Institute, The Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, China, Shenzhen, 518020, P. R. China
⨯
Jian-chuan Xia ,

* E-mail: lijj@sysucc.org.cn (JJL); xiajch@mail.sysu.edu.cn (JCX)

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯
Jian-jun Li

* E-mail: lijj@sysucc.org.cn (JJL); xiajch@mail.sysu.edu.cn (JCX)

Affiliations State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China, Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China
⨯

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

Yin Li,
Ke Pan,
Li-zhi Liu,
Yong-qiang Li,
Mo-fa Gu,
Hua Zhang,
Wei-xi Shen,
Jian-chuan Xia,
Jian-jun Li

Published: June 22, 2015
https://doi.org/10.1371/journal.pone.0130620

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Nasopharyngeal carcinoma
Is the Subject Area "Nasopharyngeal carcinoma" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.